These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2027115

  • 1. Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
    Howell DS, Pita JC, Muller FJ, Manicourt DH, Altman RD.
    J Rheumatol Suppl; 1991 Feb; 27():138-42. PubMed ID: 2027115
    [Abstract] [Full Text] [Related]

  • 2. A mini review: proteoglycan aggregate profiles in the Pond-Nuki dog model of osteoarthritis and in canine disuse atrophy.
    Howell DS, Muller F, Manicourt DH.
    Br J Rheumatol; 1992 Feb; 31 Suppl 1():7-11. PubMed ID: 1555051
    [Abstract] [Full Text] [Related]

  • 3. In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model.
    Pelletier JP, Martel-Pelletier J.
    J Rheumatol Suppl; 1991 Feb; 27():127-30. PubMed ID: 2027112
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
    Mastbergen SC, Marijnissen AC, Vianen ME, Zoer B, van Roermund PM, Bijlsma JW, Lafeber FP.
    Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
    [Abstract] [Full Text] [Related]

  • 5. The mechanism of action of nonsteroidal antiinflammatory drugs.
    Brandt KD.
    J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109
    [Abstract] [Full Text] [Related]

  • 6. Centrifugal and biochemical comparison of proteoglycan aggregates from articular cartilage in experimental joint disuse and joint instability.
    Müller FJ, Setton LA, Manicourt DH, Mow VC, Howell DS, Pita JC.
    J Orthop Res; 1994 Jul; 12(4):498-508. PubMed ID: 8064480
    [Abstract] [Full Text] [Related]

  • 7. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
    Brandt KD, Slowman-Kovacs S.
    Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
    [Abstract] [Full Text] [Related]

  • 8. In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage.
    Pelletier JP, Cloutier JM, Martel-Pelletier J.
    J Rheumatol; 1989 May; 16(5):646-55. PubMed ID: 2754669
    [Abstract] [Full Text] [Related]

  • 9. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. I. Biochemical results.
    Abatangelo G, Botti P, Del Bue M, Gei G, Samson JC, Cortivo R, De Galateo A, Martelli M.
    Clin Orthop Relat Res; 1989 Apr; (241):278-85. PubMed ID: 2924476
    [Abstract] [Full Text] [Related]

  • 10. The effects of Rumalon, a glycosaminoglycan peptide complex, in a partial meniscectomy model of osteoarthritis in rabbits.
    Moskowitz RW, Reese JH, Young RG, Fein-Krantz D, Malemud CJ, Caplan AI.
    J Rheumatol; 1991 Feb; 18(2):205-9. PubMed ID: 2023213
    [Abstract] [Full Text] [Related]

  • 11. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
    Yamada H, Watanabe K, Saito T, Hayashi H, Niitani Y, Kikuchi T, Ito A, Fujikawa K, Lohmander LS.
    J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
    [Abstract] [Full Text] [Related]

  • 12. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M, Lesur C, Thomas M, Chomel A, Anract P, de Nanteuil G, Pastoureau P.
    Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
    [Abstract] [Full Text] [Related]

  • 13. Effects of some nonsteroidal anti-inflammatory drugs on articular cartilage of rats in an experimental model of osteoarthritis.
    Gencosmanoglu BE, Eryavuz M, Dervisoglu S.
    Res Exp Med (Berl); 2001 Mar; 200(3):215-26. PubMed ID: 11426673
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of intraarticular hyaluronan injection in experimental canine osteoarthritis.
    Smith GN, Myers SL, Brandt KD, Mickler EA.
    Arthritis Rheum; 1998 Jun; 41(6):976-85. PubMed ID: 9627007
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID.
    Pelletier JP, Martel-Pelletier J.
    J Rheumatol Suppl; 1989 Aug; 18():19-27. PubMed ID: 2553967
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL, Brandt KD, Burr DB, O'Connor BL, Albrecht M.
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.